Stock Market | FinancialContent Business Page financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.
BOSTON (BUSINESS WIRE) Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company developing STAR-0215 for hereditary angioedema and focused on life-changing therapies for rare and niche allergic and immunological diseases, today announced that it has named Chris Morabito, M.D., as Chief Medical Officer..
On Track to File IND Application for STAR-0215 Mid-Year Initial Phase 1a Clinical Results Anticipated by Year End 2022 BOSTON (BUSINESS WIRE) Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company developing STAR-0215 for hereditary angioedema (HAE) and focused on life-changing therapies fo.
Catabasis Pharmaceuticals (NASDAQ:ATXS – Get Rating)‘s stock had its “buy” rating reiterated by HC Wainwright in a research report issued to clients and investors on Friday, TipRanks reports. They presently have a $13.00 price objective on the biotechnology company’s stock. HC Wainwright’s price target suggests a potential upside of 83.10% from the stock’s current price. […]
Geode Capital Management LLC Sells 117,267 Shares of Catabasis Pharmaceuticals, Inc (NASDAQ:ATXS) etfdailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from etfdailynews.com Daily Mail and Mail on Sunday newspapers.